Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma.

Autor: de Lima Lopes G Jr; Department of Oncology, Johns Hopkins Singapore International Medical Centre, 11 Jalan Tan Tock Seng, Level 1, Singapore, 308433, Singapore. glopes@imc.jhmi.edu, Dicksey JS, Peters WP, Palalay M, Chang AY

Publikováno v: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2011 Oct; Vol. 68 (4), pp. 1067-73. Date of Electronic Publication: 2011 Feb 23.